Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-07-21

FDA Approved: AMBRISENTAN — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved the Original Application for ambrisentan as a generic version by Aurobindo Pharma Limited. The drug is used for the treatment of pulmonary arterial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ambrisentan (Ambrisentan)

Snippet

ORIG AP for AMBRISENTAN (AMBRISENTAN)